⌘K

Login Start Free

Home/Filings/5/0001209191-15-014696

5//SEC Filing

CLEVELAND BIOLABS INC 5

Accession 0001209191-15-014696

CIK 0001318641operating

View on SEC.gov Company Profile

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 5:59 PM ET

Size

5.5 KB

Accession

0001209191-15-014696

Insider Transaction Report

Form 5

Period: 2014-12-31

CLEVELAND BIOLABS INCCBLI

SALUCK RANDY S.

Director

Transactions

Award
Stock Option (right to buy)
2014-06-11+1,750→ 1,750 total
Exercise: $9.80From: 2014-06-11Exp: 2024-06-11→ Common Stock (1,750 underlying)

Footnotes (1)

[F1]As adjusted for 20-to-1 reverse stock split, effective January 28, 2015.

Documents

1 file

5
doc5.xmlPrimary
FORM 5 SUBMISSION

Issuer

CLEVELAND BIOLABS INC

CIK 0001318641

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001318641

Filing Metadata

Form type: 5
Filed: Feb 16, 7:00 PM ET
Accepted: Feb 17, 5:59 PM ET
Size: 5.5 KB

View on SEC.gov